NCT06275360 2026-03-02
RIVAL
VA Office of Research and Development
Phase 2 Recruiting
Clinical Trials
37 trialsNCT04104893 2026-02-27
CHOMP
VA Office of Research and Development
Phase 2 Active not recruiting
NCT04515004 2026-02-17
Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer
VA Office of Research and Development
Phase 2 Terminated
NCT05796375 2026-01-30
ReplaceCysto
White River Junction Veterans Affairs Medical Center
Phase 2 Recruiting
NCT06084338 2025-12-31
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc
VA Office of Research and Development
Phase 2 Recruiting
NCT06778434 2025-12-22
The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans
VA Office of Research and Development
Phase 2 Recruiting
NCT03298087 2025-08-01
Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer
VA Office of Research and Development
Phase 2 Completed
NCT06610825 2025-07-28
CaRPET
Washington D.C. Veterans Affairs Medical Center
Phase 2 Recruiting
NCT05011383 2025-07-09
VA-BAT
VA Office of Research and Development
Phase 2 Recruiting
NCT04390880 2025-05-16
PROSPYL
VA Greater Los Angeles Healthcare System
Phase 2 Completed
NCT05593497 2025-04-16
SNARE
VA Office of Research and Development
Phase 2 Recruiting
NCT01759771 2024-03-18
VD3PCa
VA Office of Research and Development
Phase 2 Completed
NCT05820724 2023-04-24
PSMA PET Scan and mpMRI for Prostate Cancer Detection
VA Greater Los Angeles Healthcare System
Phase 2 Not yet recruiting
NCT04116775 2022-06-23
Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer.
Portland VA Medical Center
Phase 2 Unknown
NCT05422911 2022-06-21
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
James J. Peters Veterans Affairs Medical Center
Phase 2 Not yet recruiting
NCT03753243 2022-04-20
Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
Portland VA Medical Center
Phase 2 Recruiting
NCT04018872 2021-11-04
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Dallas VA Medical Center
Phase 2 Recruiting
NCT04489745 2020-07-28
Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer
VA Greater Los Angeles Healthcare System
Phase 2 Unknown
NCT00524277 2020-03-30
Vaccine Therapy in Treating Patients With Breast Cancer
San Antonio Military Medical Center
Phase 2 Completed
NCT01754909 2019-10-08
Mitigation of Radiation Pneumonitis and Fibrosis
VA Office of Research and Development
Phase 2 Completed
NCT01505764 2018-07-17
The Role of Ghrelin in Cancer Cachexia
VA Office of Research and Development
Phase 2 Terminated
NCT00105599 2015-04-07
Effectiveness of the FairCare System for Patients With Advanced Illness
VA Office of Research and Development
Phase 2 Completed
NCT00004437 2015-03-25
Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2
FDA Office of Orphan Products Development
Phase 2 Completed
NCT00004688 2015-03-25
Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms
FDA Office of Orphan Products Development
Phase 2 Completed
NCT00056992 2015-03-25
Testing of ADI-PEG in Hepatocellular Carcinoma
FDA Office of Orphan Products Development
Phase 2 Completed
NCT00086203 2015-03-25
Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
FDA Office of Orphan Products Development
Phase 2 Completed
NCT00098033 2015-03-25
Investigation of Clofarabine in Acute Leukemias
FDA Office of Orphan Products Development
Phase 2 Completed
NCT00099593 2015-03-25
Immunization Against Tumor Cells in Sezary Syndrome
FDA Office of Orphan Products Development
Phase 2 Completed
NCT01032928 2015-01-01
RSPT
VA Office of Research and Development
Phase 2 Completed
NCT00100477 2013-09-25
Use of Topotecan in Patients With Refractory Acute Leukemia
VA Office of Research and Development
Phase 2 Completed
NCT01417806 2011-08-16
Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung Cancer
South Florida Veterans Affairs Foundation for Research and Education
Phase 2 Unknown
NCT00018538 2009-01-21
Calcifidol Therapy in Men With Cancer
VA Office of Research and Development
Phase 2 Completed
NCT00018551 2009-01-21
Chemoprevention With Folic Acid
VA Office of Research and Development
Phase 2 Completed
NCT00728520 2008-08-06
Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction Therapy
Kansas City Veteran Affairs Medical Center
Phase 2 Unknown
NCT00108290 2008-04-04
Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer
VA Office of Research and Development
Phase 2 Completed
NCT00215345 2005-09-22
A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer
Department of Veterans Affairs, New Jersey
Phase 2 Unknown
NCT00218205 2005-09-22
A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer
Department of Veterans Affairs, New Jersey
Phase 2 Unknown